The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.
Tumors With KRAS G12C Mutation Respond to Adagrasib and Using Toripalimab to Treat Stage III Lung Cancer: The ASCO Plenary Series
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery.
Evaluating Targeted Therapy for People With Advanced Gastric or Gastroesophageal Junction Cancer: The ASCO Plenary Series
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer.
Plant-Based Diets and a New Treatment Combination for Prostate Cancer: Research from the 2023 Genitourinary Cancers Symposium
Read about two studies presented at the 2023 Genitourinary Cancers Symposium, covering plant-based diets and prostate cancer and a promising combination treatment for metastatic castration-resistant prostate cancer.
Read research from the February 2023 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapy drugs for treating people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
New Research in Treating Non-Hodgkin Lymphoma and Predicting the Risk of Early Disease Progression: ASH Annual Meeting 2022
In this podcast, Dr. Christopher Flowers discusses new research from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, including new treatments for non-Hodgkin lymphoma and models for predicting early disease progression.
Using a Blood Test to Select Treatments for Advanced Gastrointestinal Stromal Tumors (GISTs): The ASCO Plenary Series
Read research from the January 2023 session of the ASCO Plenary Series, which highlights a study evaluating a blood-based test to select treatment for advanced gastrointestinal stromal tumors (GISTs).
In this podcast, Dr. Fay Hlubocky and Dr. Manali Patel discuss what health equity and quality care mean in the context of cancer care and describe research highlights in these areas from the 2022 Quality Care Symposium.
Immunotherapy Combination That Targets TIGIT Receptor Shows Promise in Non-Small Cell Lung Cancer: The ASCO Plenary Series
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1.
In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer.